{"id":440069,"date":"2021-02-19T13:03:48","date_gmt":"2021-02-19T18:03:48","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=440069"},"modified":"2021-02-19T13:03:48","modified_gmt":"2021-02-19T18:03:48","slug":"vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/","title":{"rendered":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Feb.  19, 2021  (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) from June 1, 2017 through November 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Voyager Therapeutics, Inc. investors under the federal securities laws.<\/p>\n<p>To join the class action, go <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PV9ixaZiAiFLy5ufxQmpfpnuYWSGAR5heXiUveS3qjwPoO8ABbzES5sQjgV7yUi3M9VIA_ioe_QRGMnNlEEv8anGO4psi2C7ZstsdRj2cHFctzKGnWk3lxuY_fNFy4GUa_NnemojcBQi5l0Db0fPOg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">here<\/a> or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X5B7y8mgTCkazkxNSXz__MKiImmlCyRitZ7rCikm20guSG7FwMfdq4bKpwAROYVorDgcRN2UGM1dI0or8UmcYy763Y8d3ar09Bk5J-Cz7D8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@pawarlawgroup.com<\/a>\u00a0for information on the class action.<\/p>\n<p>According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: the Company\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (\u201cCMC\u201d) matters, including, inter alia, drug-device compatibility and drug substance and product characterization; the Company\u2019s IND submission for VY-HTT01 was therefore deficient; the Company had thus materially overstated the likelihood of FDA approval for VY-HTT01 based on the IND submission; and as a result, the Company\u2019s public statements were materially false and misleading at all relevant times.<\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court no later than <strong>March 24, 2021.<\/strong> A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.<\/p>\n<p>No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.<\/p>\n<p>Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.<br \/>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-<\/p>\n<p>Contact:\u00a0\u00a0<br \/>Vik Pawar, Esq.\u00a0\u00a0<br \/>Pawar Law Group\u00a0\u00a0<br \/>20 Vesey Street, Suite 1410\u00a0\u00a0<br \/>New York, NY 10007\u00a0\u00a0<br \/>Tel: (917) 261-2277\u00a0\u00a0<br \/>Fax: (212) 571-0938\u00a0\u00a0<br \/>info@pawarlawgroup.com\u00a0\u00a0<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4ce14feb-37a4-43bd-aeb2-c4b8e8c1b17f\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) from June 1, 2017 through November 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Voyager Therapeutics, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: the Company\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (\u201cCMC\u201d) matters, including, inter alia, drug-device compatibility and drug &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-440069","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) from June 1, 2017 through November 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Voyager Therapeutics, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: the Company\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (\u201cCMC\u201d) matters, including, inter alia, drug-device compatibility and drug &hellip; Continue reading &quot;VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-19T18:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR\",\"datePublished\":\"2021-02-19T18:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/\",\"name\":\"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\",\"datePublished\":\"2021-02-19T18:03:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/","og_locale":"en_US","og_type":"article","og_title":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk","og_description":"NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) &#8212; Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of Voyager Therapeutics, Inc. (NASDAQ: VYGR) from June 1, 2017 through November 9, 2020, inclusive (the \u201cClass Period\u201d). The lawsuit seeks to recover damages for Voyager Therapeutics, Inc. investors under the federal securities laws. To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email\u00a0info@pawarlawgroup.com\u00a0for information on the class action. According to the lawsuit, \u00a0defendants made false and\/or misleading statements and\/or failed to disclose that: the Company\u2019s VY-HTT01 IND submission to the FDA lacked key information regarding certain chemistry, manufacturing and controls (\u201cCMC\u201d) matters, including, inter alia, drug-device compatibility and drug &hellip; Continue reading \"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-19T18:03:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR","datePublished":"2021-02-19T18:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/"},"wordCount":330,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/","name":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=","datePublished":"2021-02-19T18:03:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NjM4MSMzOTg1OTg4IzIwODMxNDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vygr-alert-pawar-law-group-announces-a-securities-class-action-lawsuit-against-voyager-therapeutics-inc-vygr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"VYGR ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Voyager Therapeutics, Inc.\u2013 VYGR"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=440069"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/440069\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=440069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=440069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=440069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}